Table 4.
Effects of AESS and VESS on the content of Ca2+ and NO in the uterus tissue homogenate (
± s, n = 10)#.
| Group | Dose (g/kg) | Ca2+/ mmol·gprot-1 | NO/ μmol·gprot-1 | |
|---|---|---|---|---|
| Normal group | - | 0.08 ± 0.07 | 9.12 ± 3.24 | |
| Control group | - | 0.44 ± 0.21 | 18.62 ± 4.12 | |
| Celecoxib group | 0.0411 | 0.20 ± 0.14 | 18.73 ± 7.25 | |
| AESS group | High dose | 4.90 | 0.13 ± 0.07* | 9.15 ± 2.34* |
| Low dose | 2.45 | 0.22 ± 0.12* | 11.98 ± 3.44* | |
| VESS group | High dose | 10.06 | 0.11 ± 0.18* | 9.02 ± 2.95* |
| Low dose | 5.03 | 0.13 ± 0.11* | 10.46 ± 3.05* | |
The crude extracts were ensured to be equal in dose converting into crude plant materials, and the doses of crude plant materials for two extracts are equal; # Values are expressed as mean ± standard deviations (n = 10); * Level of significance relative to the control value P < 0.05.